These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
427 related articles for article (PubMed ID: 31019077)
1. Cystine-glutamate antiporter xCT deficiency suppresses tumor growth while preserving antitumor immunity. Arensman MD; Yang XS; Leahy DM; Toral-Barza L; Mileski M; Rosfjord EC; Wang F; Deng S; Myers JS; Abraham RT; Eng CH Proc Natl Acad Sci U S A; 2019 May; 116(19):9533-9542. PubMed ID: 31019077 [TBL] [Abstract][Full Text] [Related]
2. Cystine/glutamate antiporter xCT deficiency reduces metastasis without impairing immune system function in breast cancer mouse models. Ruiu R; Cossu C; Iacoviello A; Conti L; Bolli E; Ponzone L; Magri J; Rumandla A; Calautti E; Cavallo F J Exp Clin Cancer Res; 2023 Sep; 42(1):254. PubMed ID: 37770957 [TBL] [Abstract][Full Text] [Related]
3. Cystine/glutamate antiporter xCT (SLC7A11) facilitates oncogenic RAS transformation by preserving intracellular redox balance. Lim JKM; Delaidelli A; Minaker SW; Zhang HF; Colovic M; Yang H; Negri GL; von Karstedt S; Lockwood WW; Schaffer P; Leprivier G; Sorensen PH Proc Natl Acad Sci U S A; 2019 May; 116(19):9433-9442. PubMed ID: 31000598 [TBL] [Abstract][Full Text] [Related]
4. Immunotargeting of the xCT Cystine/Glutamate Antiporter Potentiates the Efficacy of HER2-Targeted Immunotherapies in Breast Cancer. Conti L; Bolli E; Di Lorenzo A; Franceschi V; Macchi F; Riccardo F; Ruiu R; Russo L; Quaglino E; Donofrio G; Cavallo F Cancer Immunol Res; 2020 Aug; 8(8):1039-1053. PubMed ID: 32532810 [TBL] [Abstract][Full Text] [Related]
5. Redox imbalance in cystine/glutamate transporter-deficient mice. Sato H; Shiiya A; Kimata M; Maebara K; Tamba M; Sakakura Y; Makino N; Sugiyama F; Yagami K; Moriguchi T; Takahashi S; Bannai S J Biol Chem; 2005 Nov; 280(45):37423-9. PubMed ID: 16144837 [TBL] [Abstract][Full Text] [Related]
6. Absence of system x Merckx E; Albertini G; Paterka M; Jensen C; Albrecht P; Dietrich M; Van Liefferinge J; Bentea E; Verbruggen L; Demuyser T; Deneyer L; Lewerenz J; van Loo G; De Keyser J; Sato H; Maher P; Methner A; Massie A J Neuroinflammation; 2017 Jan; 14(1):9. PubMed ID: 28086920 [TBL] [Abstract][Full Text] [Related]
7. Burn injury induces the expression of cystine/glutamate transporter (x(c)(-)) in mouse T cells. D'Elia M; Patenaude J; Dupras C; Bernier J Immunol Lett; 2009 Aug; 125(2):137-44. PubMed ID: 19576933 [TBL] [Abstract][Full Text] [Related]
8. Cystine/glutamate transporter, system x Kobayashi S; Hamashima S; Homma T; Sato M; Kusumi R; Bannai S; Fujii J; Sato H Nitric Oxide; 2018 Aug; 78():32-40. PubMed ID: 29792932 [TBL] [Abstract][Full Text] [Related]
9. Vasodilator oxyfedrine inhibits aldehyde metabolism and thereby sensitizes cancer cells to xCT-targeted therapy. Otsuki Y; Yamasaki J; Suina K; Okazaki S; Koike N; Saya H; Nagano O Cancer Sci; 2020 Jan; 111(1):127-136. PubMed ID: 31692172 [TBL] [Abstract][Full Text] [Related]
10. Suppression of the xCT-CD44v antiporter system sensitizes triple-negative breast cancer cells to doxorubicin. Wang F; Yang Y Breast Cancer Res Treat; 2014 Aug; 147(1):203-10. PubMed ID: 25085754 [TBL] [Abstract][Full Text] [Related]
11. Cystine/glutamate exchange modulates glutathione supply for neuroprotection from oxidative stress and cell proliferation. Shih AY; Erb H; Sun X; Toda S; Kalivas PW; Murphy TH J Neurosci; 2006 Oct; 26(41):10514-23. PubMed ID: 17035536 [TBL] [Abstract][Full Text] [Related]
12. Functional interactions of the cystine/glutamate antiporter, CD44v and MUC1-C oncoprotein in triple-negative breast cancer cells. Hasegawa M; Takahashi H; Rajabi H; Alam M; Suzuki Y; Yin L; Tagde A; Maeda T; Hiraki M; Sukhatme VP; Kufe D Oncotarget; 2016 Mar; 7(11):11756-69. PubMed ID: 26930718 [TBL] [Abstract][Full Text] [Related]
13. Negative regulation of osteoblastogenesis through downregulation of runt-related transcription factor-2 in osteoblastic MC3T3-E1 cells with stable overexpression of the cystine/glutamate antiporter xCT subunit. Uno K; Takarada T; Takarada-Iemata M; Nakamura Y; Fujita H; Hinoi E; Yoneda Y J Cell Physiol; 2011 Nov; 226(11):2953-64. PubMed ID: 21302293 [TBL] [Abstract][Full Text] [Related]
14. The role of system Xc Dang DK; Shin EJ; Tran HQ; Kim DJ; Jeong JH; Jang CG; Nah SY; Sato H; Nabeshima T; Yoneda Y; Kim HC Neurochem Int; 2017 Sep; 108():254-265. PubMed ID: 28457879 [TBL] [Abstract][Full Text] [Related]
15. The glutamate/cystine xCT antiporter antagonizes glutamine metabolism and reduces nutrient flexibility. Shin CS; Mishra P; Watrous JD; Carelli V; D'Aurelio M; Jain M; Chan DC Nat Commun; 2017 Apr; 8():15074. PubMed ID: 28429737 [TBL] [Abstract][Full Text] [Related]
16. Oncogenic PI3K promotes methionine dependency in breast cancer cells through the cystine-glutamate antiporter xCT. Lien EC; Ghisolfi L; Geck RC; Asara JM; Toker A Sci Signal; 2017 Dec; 10(510):. PubMed ID: 29259101 [TBL] [Abstract][Full Text] [Related]
17. Aspirin plus sorafenib potentiates cisplatin cytotoxicity in resistant head and neck cancer cells through xCT inhibition. Roh JL; Kim EH; Jang H; Shin D Free Radic Biol Med; 2017 Mar; 104():1-9. PubMed ID: 28057599 [TBL] [Abstract][Full Text] [Related]
18. Dopaminergic neurons of system x(c)⁻-deficient mice are highly protected against 6-hydroxydopamine-induced toxicity. Massie A; Schallier A; Kim SW; Fernando R; Kobayashi S; Beck H; De Bundel D; Vermoesen K; Bannai S; Smolders I; Conrad M; Plesnila N; Sato H; Michotte Y FASEB J; 2011 Apr; 25(4):1359-69. PubMed ID: 21191088 [TBL] [Abstract][Full Text] [Related]
19. Mapping of the cystine-glutamate exchanger in the mouse eye: a role for xCT in controlling extracellular redox balance. Martis RM; Donaldson PJ; Li B; Middleditch M; Kallingappa PK; Lim JC Histochem Cell Biol; 2019 Oct; 152(4):293-310. PubMed ID: 31396687 [TBL] [Abstract][Full Text] [Related]
20. Cystine uptake through the cystine/glutamate antiporter xCT triggers glioblastoma cell death under glucose deprivation. Goji T; Takahara K; Negishi M; Katoh H J Biol Chem; 2017 Dec; 292(48):19721-19732. PubMed ID: 29038291 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]